We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$512M
AUM Growth
+$116M
Cap. Flow
+$65.9M
Cap. Flow %
12.88%
Top 10 Hldgs %
44.62%
Holding
138
New
35
Increased
30
Reduced
28
Closed
26

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$31.8M
2
BIIB icon
Biogen
BIIB
+$21.2M
3
NVS icon
Novartis
NVS
+$19M
4
PFE icon
Pfizer
PFE
+$13M
5
CELG
Celgene Corp
CELG
+$8.38M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$13.8M
2
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
+$13M
3
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$11.9M
4
MRK icon
Merck
MRK
+$9.86M
5
AKAO
Achaogen Inc
AKAO
+$6.46M

Sector Composition

Rank Sector Weight
1 Healthcare 64.14%
2 Miscellaneous 24.59%
3 Technology 4.38%
4 Communication Services 1.99%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRVN
101
DELISTED
Trevena, Inc.
TRVN
$429K 0.08%
+187
New +$637K
UNH icon
102
UnitedHealth
UNH
$337B
$328K 0.06%
2,000
+300
+18% +$49.1K
MHK icon
103
Mohawk Industries
MHK
$8.7B
$252K 0.05%
1,100
– –
LOW icon
104
Lowe's Companies
LOW
$109B
$214K 0.04%
2,600
– –
TMX
105
DELISTED
Terminix Global Holdings, Inc.
TMX
$209K 0.04%
+7,465
New +$194K
SEE
106
DELISTED
Sealed Air
SEE
$196K 0.04%
4,500
+1,000
+29% +$47K
CMG icon
107
Chipotle Mexican Grill
CMG
$42.4B
$178K 0.03%
+20,000
New +$165K
TRIP icon
108
TripAdvisor
TRIP
$1.04B
$173K 0.03%
+4,000
New +$190K
ULTI
109
DELISTED
Ultimate Software Group Inc
ULTI
$156K 0.03%
+800
New +$156K
KRNT icon
110
Kornit Digital
KRNT
$661M
$17K ﹤0.01%
+900
New +$14.8K
ATHX
111
DELISTED
Athersys, Inc. Common Stock
ATHX
$1K ﹤0.01%
+31
New +$991
ABUS icon
112
Arbutus Biopharma
ABUS
$1B
– –
-22,000
Closed -$54K
APD icon
113
Air Products & Chemicals
APD
$63.7B
– –
-21,165
Closed -$3.04M
AZN icon
114
AstraZeneca
AZN
$258B
– –
-25,000
Closed -$1.37M
BA icon
115
Boeing
BA
$156B
– –
-8,392
Closed -$1.31M
BMRN icon
116
BioMarin Pharmaceuticals
BMRN
$12.6B
– –
-45,000
Closed -$3.73M
CABO icon
117
Cable One
CABO
$103M
– –
-500
Closed -$311K
CTSH icon
118
Cognizant
CTSH
$27.9B
– –
-27,875
Closed -$1.56M
FIS icon
119
Fidelity National Information Services
FIS
$18.8B
– –
-43,503
Closed -$3.29M
OTLK icon
120
Outlook Therapeutics
OTLK
$166M
– –
-1,090
Closed -$525K
PANW icon
121
Palo Alto Networks
PANW
$307B
– –
-42,312
Closed -$882K
PCRX icon
122
Pacira BioSciences
PCRX
$976M
– –
-50,000
Closed -$1.61M
PTCT icon
123
PTC Therapeutics
PTCT
$5.68B
– –
-150,000
Closed -$1.64M
SITE icon
124
SiteOne Landscape Supply
SITE
$3.89B
– –
-8,820
Closed -$306K
VRTX icon
125
Vertex Pharmaceuticals
VRTX
$131B
– –
-45,000
Closed -$3.31M
2 3 4
5
6

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q1 2017 Portfolio in Review

As of Q1 2017, Sphera Funds Management held 138 positions worth $512M, up 29% from $395M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sphera Funds Management deployed $65.9M of net new capital in Q1 2017, opening 35 new positions and adding to 30 existing holdings. Its largest new stake was Biogen: 75,000 shares worth $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 67% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Teva Pharmaceutical Industries Limited, an estimated $11.9M trimmed.

  • Sphera Funds Management's largest Q1 2017 buy was Biogen: 75,000 shares worth $20.5M.
  • Sphera Funds Management added most to Shire pic in Q1 2017, an estimated $31.8M increase.
  • Sphera Funds Management's biggest Q1 2017 reduction was Teva Pharmaceutical Industries Limited, cutting an estimated $11.9M.
  • Sphera Funds Management fully exited Alexion Pharmaceuticals in Q1 2017, selling an estimated $13.8M.
  • Sphera Funds Management's ten largest holdings make up 45% of its $512M portfolio in Q1 2017.
  • Sphera Funds Management opened 35 new positions and closed 26 in Q1 2017.
  • Sphera Funds Management's portfolio value rose 29% quarter-over-quarter to $512M.

Based on Sphera Funds Management's 13F filing for Q1 2017, filed 11 May 2017.